/CE Catalog|
FP&A Rolling Forecasts, AI Variance Modeling, WACC Capital Allocation & M&A Working Capital Disputes
FP&A Rolling Forecasts, AI Variance Modeling, WACC Capital Allocation & M&A Working Capital Disputes
Follows the VP of FP&A and Corporate Development Lead at Apex MedTech across a turbulent fiscal year and $185M bolt-on acquisition—decomposing a mysterious 420-bps gross-margin collapse via Price-Volume-Mix variance math, catching an ML forecast data-leakage bug, correcting a single-WACC divisional capital-allocation error, and arbitrating an $8.7M post-closing M&A Net Working Capital peg dispute.
Price-Volume-Mix (PVM) Gross Margin Decomposition & Driver-Based 18-Month Rolling Forecasts
The fluorescent lights of the Apex MedTech board room hummed, casting a stark glow on the Q3 FY24 financial results. Sarah Chen, VP of FP&A, felt the familiar knot tighten in her stomach. Despite a robust +9% top-line unit growth, the gross margin had inexplicably collapsed by 420 basis points, translating directly to a $6.4 million EBITDA shortfall against the annual budget. The CEO's gaze was piercing. 'Sarah, our revenue is up, but our profitability is down. What's happening? Is this a pricing issue, a cost issue, or something else entirely?' The preliminary 'WP-GM-Q3-24-001' workpaper, a simple variance analysis, offered no granular answers, merely highlighting the aggregate miss. The board was demanding immediate clarity and a credible path to recovery. Investor confidence, already fragile in a volatile market, hung in the balance. Sarah knew a deeper, multi-dimensional analysis was required, one that could unmask the true drivers behind the margin erosion, beyond superficial revenue gains.